Pharminent

Novartis heart drug success opens up new care option

A Novartis anti-inflammatory drug cut cardiovascular risk for heart attack survivors in a pivotal trial, potentially changing ideas about treatment. http://www.cnbc.com/2017/06/22/novartis-heart-drug-success-opens-up-new-care-option.html

Filed under: Cardiovascular